The Burden of Pancreatic Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction up to 2036: A Systemic Analysis of the Global Burden of Diseases Study 2021
Cancer Medicine · 2025
DOI: 10.1002/cam4.70656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Tianhao Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health and Regimen, Jiangsu Open University, Nanjing, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Global Burden of Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, NATCM's Project of High-level Construction of Key TCM Disciplines.
Abstract (Originalsprache)
Background
Pancreatic cancer (PC) presents a significant challenge for prevention and treatment, posing a serious threat to the health and lives of patients. The five East Asian countries (China, Japan, North Korea, South Korea, and Mongolia) represent one of the most significant regions globally in terms of PC burden.
Methods
We retrieved data from the Global Burden of Disease (GBD) Study 2021 regarding the prevalence, incidence, mortality, years lived with disability (YLDs), years of life lost (YLLs), and disability‐adjusted life years (DALYs) associated with PC in these five East Asian countries from 1990 to 2021. We employed joinpoint, age‐period‐cohort (APC), and decomposition analysis methods to assess the epidemiological characteristics of PC. To project the future burden of PC through 2036, we applied two prediction models: Autoregressive Integrated Moving Average (ARIMA) and Bayesian age‐period‐cohort (BAPC) models.
Results
China recorded the highest incidence, prevalence, mortality, YLLs, YLDs, and DALYs among the five East Asian countries in both 1990 and 2021. Japan exhibited the highest age‐standardized incidence rate (ASIR), age‐standardized mortality rate (ASMR), age‐standardized prevalence rate (ASPR), and age‐standardized YLDs rate in both 1990 and 2021. Mongolia experienced significant increases in the number and rates of incidence, prevalence, death, YLLs, YLDs, and DALYs from 1990 to 2021. The age group with the highest prevalence, incidence, mortality, YLDs, YLLs, and DALYs rates across the five East Asian countries was consistently those aged 70 and older. The incidence rate across the five countries is influenced by aging populations, surpassing global averages. Projections for 2030 and 2036 suggest that Japan will have the highest ASPR (13.23 in 2030 and 13.85 in 2036), ASIR (12.14 in 2030 and 12.53 in 2036), and ASMR (10.97 in 2030 and 11.39 in 2036) among the countries.
Conclusion
The disease burden of PC in the five East Asian countries has steadily increased over the past three decades, particularly among older adults due to population aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Health and Regimen, Jiangsu Open University, Nanjing, Jiangsu, People's Republic of China.
- Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing, Jiangsu, People's Republic of China.
- The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People's Republic of China.
- Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
- Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People's Republic of China.
ORCID-Profile: Tianhao Guo, Wenjian Zhu, Yifan Hui, Tingting Zhou, Haibo Cheng
Förderung
- National Key Research and Development Program of China
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- NATCM's Project of High-level Construction of Key TCM Disciplines
- Qing Lan Project of Jiangsu Higher Education Institutions
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- General project of Universities' philosophy and social science in Jiangsu Province
Zitieren
APA
Guo, T., Zhu, W., Hui, Y., Wang, Y., Zhou, T., Shen, W., Li, L., Yang, Y., & Cheng, H. (2025). The Burden of Pancreatic Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction up to 2036: A Systemic Analysis of the Global Burden of Diseases Study 2021. Cancer Medicine. https://doi.org/10.1002/cam4.70656
Vancouver
Guo T, Zhu W, Hui Y, Wang Y, Zhou T, Shen W, et al. The Burden of Pancreatic Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction up to 2036: A Systemic Analysis of the Global Burden of Diseases Study 2021. Cancer Medicine. 2025. doi:10.1002/cam4.70656
BibTeX
@article{Guo2025,
author = {Guo, Tianhao and Zhu, Wenjian and Hui, Yifan and Wang, Yuhan and Zhou, Tingting and Shen, Weixing and Li, Liu and Yang, Yu and Cheng, Haibo},
title = {The Burden of Pancreatic Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction up to 2036: A Systemic Analysis of the Global Burden of Diseases Study 2021},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70656}
}
EUVIMED